Journal of Biological Chemistry,
Год журнала:
2023,
Номер
299(8), С. 104975 - 104975
Опубликована: Июль 8, 2023
Diabetes
mellitus
is
the
leading
cause
of
cardiovascular
and
renal
disease
in
United
-States.
Despite
beneficial
interventions
available
for
patients
with
diabetes,
there
remains
a
need
additional
therapeutic
targets
therapies
diabetic
kidney
(DKD).
Inflammation
oxidative
stress
are
increasingly
recognized
as
important
causes
diseases.
closely
associated
mitochondrial
damage.
The
molecular
connection
between
inflammation
metabolism
to
be
elucidated.
Recently,
nicotinamide
adenine
nucleotide
(NAD+)
has
been
found
regulate
immune
function
inflammation.
In
present
studies,
we
tested
hypothesis
that
enhancing
NAD
could
prevent
progression
DKD.
We
treatment
db/db
mice
type
2
diabetes
riboside
(NR)
prevented
several
manifestations
dysfunction
(i.e.,
albuminuria,
increased
urinary
injury
marker-1
(KIM1)
excretion,
pathologic
changes).
These
effects
were
decreased
inflammation,
at
least
part
via
inhibiting
activation
cyclic
GMP-AMP
synthase-stimulator
interferon
genes
(cGAS-STING)
signaling
pathway.
An
antagonist
serum
stimulator
(STING)
whole-body
STING
deletion
showed
similar
renoprotection.
Further
analysis
NR
SIRT3
activity
improved
function,
which
led
DNA
damage,
trigger
leakage
activates
cGAS-STING
Overall,
these
data
show
supplementation
boosted
augment
reducing
thereby
preventing
disease.
JACC Basic to Translational Science,
Год журнала:
2022,
Номер
7(12), С. 1183 - 1196
Опубликована: Сен. 14, 2022
The
mitochondrial
dysfunction
characteristic
of
heart
failure
(HF)
is
associated
with
changes
in
intracellular
nicotinamide
adenine
dinucleotide
(NAD+)
and
NADH
levels.
Raising
NAD+
levels
the
precursor,
riboside
(NR),
may
represent
a
novel
HF
treatment.
In
this
30-participant
trial
patients
clinically
stable
reduced
ejection
fraction,
NR,
at
dose
1,000
mg
twice
daily,
appeared
to
be
safe
well
tolerated,
approximately
doubled
whole
blood
Intraindividual
increases
response
NR
correlated
peripheral
mononuclear
cell
basal
(R2
=
0.413,
P
0.003)
maximal
0.434,
0.002)
respiration,
decreased
NLRP3
expression
0.330,
0.020).
(Nicotinamide
Riboside
Systolic
Heart
Failure;
NCT03423342)
Journal of Clinical Investigation,
Год журнала:
2022,
Номер
132(5)
Опубликована: Янв. 13, 2022
BACKGROUNDFasting
and
NAD+-boosting
compounds,
including
NAD+
precursor
nicotinamide
riboside
(NR),
confer
antiinflammatory
effects.
However,
the
underlying
mechanisms
therapeutic
potential
are
incompletely
defined.METHODSWe
explored
biology
in
myeloid
cells
from
healthy
volunteers
following
vivo
placebo
or
NR
administration
subsequently
tested
findings
vitro
monocytes
extracted
patients
with
systemic
lupus
erythematosus
(SLE).RESULTSRNA-Seq
of
unstimulated
LPS-activated
implicated
regulation
autophagy
type
I
IFN
signaling.
In
primary
monocytes,
blunted
LPS-induced
IFN-β
production,
genetic
pharmacological
disruption
phenocopied
this
effect.
Given
that
is
a
coenzyme
oxidoreductive
reactions,
metabolomics
was
performed
identified
increased
inosine
level.
Inosine
supplementation
similarly
release.
Finally,
because
SLE
exhibits
dysregulation,
we
assessed
effect
on
found
reduced
release.CONCLUSIONWe
conclude
NR,
an
NAD+-dependent
manner
part
via
signaling,
mediated
suppression
attenuated
cells,
as
adjunct
for
management.TRIAL
REGISTRATIONClinicalTrials.gov
registration
numbers
NCT02812238,
NCT00001846,
NCT00001372.FUNDINGThis
work
supported
by
NHLBI
NIAMS
Intramural
Research
divisions.
The
risk
of
morbidity
and
mortality
increases
exponentially
with
age.
Chronic
inflammation,
accumulation
DNA
damage,
dysfunctional
mitochondria,
increased
senescent
cell
load
are
factors
contributing
to
this.
Mechanistic
investigations
have
revealed
specific
pathways
processes
which,
proposedly,
cause
age-related
phenotypes
such
as
frailty,
reduced
physical
resilience,
multi-morbidity.
Among
promising
treatments
alleviating
the
consequences
aging
caloric
restriction
pharmacologically
targeting
longevity
mechanistic
target
rapamycin
(mTOR),
sirtuins,
anti-apoptotic
in
cells.
Regulation
these
has
significant
health-
lifespan
extending
results
animal
models.
Nevertheless,
it
remains
unclear
if
similar
translate
humans.
A
requirement
translation
development
age-
associated
biomarkers
longitudinal
trials
difficult
not
feasible,
practical,
nor
ethical
when
human
life
span
is
endpoint.
Current
anti-aging
intervention
studies
humans
will
be
covered
within
this
paper.
future
clinical
may
phase
2
3
larger
populations
safety
tolerability
investigated
medication
continues
a
hurdle
for
further
investigations.
Advances in Nutrition,
Год журнала:
2023,
Номер
14(6), С. 1416 - 1435
Опубликована: Авг. 23, 2023
The
importance
of
nicotinamide
adenine
dinucleotide
(NAD+)
in
human
physiology
is
well
recognized.
As
the
NAD+
concentration
skin,
blood,
liver,
muscle
and
brain
are
thought
to
decrease
with
age,
finding
ways
increase
status
could
possibly
influence
ageing
process
associated
metabolic
sequelae.
Nicotinamide
mononucleotide
(NMN)
a
precursor
for
biosynthesis,
vitro/in
vivo
studies
have
demonstrated
that
NMN
supplementation
increases
mitigate
ageing-related
disorders
such
as
oxidative
stress,
DNA
damage,
neurodegeneration
inflammatory
responses.
promotion
an
anti-ageing
health
supplement
has
gained
popularity
due
findings;
however,
since
most
evaluating
effects
been
conducted
cell
or
animal
models,
concern
remains
regarding
safety
physiological
population.
Nonetheless,
dozen
clinical
trials
currently
underway.
This
review
summarizes
current
progress
these
NMN/NAD+
biology
clarify
potential
shed
light
on
future
study
directions.
Journal of Biological Chemistry,
Год журнала:
2023,
Номер
299(8), С. 104975 - 104975
Опубликована: Июль 8, 2023
Diabetes
mellitus
is
the
leading
cause
of
cardiovascular
and
renal
disease
in
United
-States.
Despite
beneficial
interventions
available
for
patients
with
diabetes,
there
remains
a
need
additional
therapeutic
targets
therapies
diabetic
kidney
(DKD).
Inflammation
oxidative
stress
are
increasingly
recognized
as
important
causes
diseases.
closely
associated
mitochondrial
damage.
The
molecular
connection
between
inflammation
metabolism
to
be
elucidated.
Recently,
nicotinamide
adenine
nucleotide
(NAD+)
has
been
found
regulate
immune
function
inflammation.
In
present
studies,
we
tested
hypothesis
that
enhancing
NAD
could
prevent
progression
DKD.
We
treatment
db/db
mice
type
2
diabetes
riboside
(NR)
prevented
several
manifestations
dysfunction
(i.e.,
albuminuria,
increased
urinary
injury
marker-1
(KIM1)
excretion,
pathologic
changes).
These
effects
were
decreased
inflammation,
at
least
part
via
inhibiting
activation
cyclic
GMP-AMP
synthase-stimulator
interferon
genes
(cGAS-STING)
signaling
pathway.
An
antagonist
serum
stimulator
(STING)
whole-body
STING
deletion
showed
similar
renoprotection.
Further
analysis
NR
SIRT3
activity
improved
function,
which
led
DNA
damage,
trigger
leakage
activates
cGAS-STING
Overall,
these
data
show
supplementation
boosted
augment
reducing
thereby
preventing
disease.